Connection

Mark Kindy to Brain

This is a "connection" page, showing publications Mark Kindy has written about Brain.
Connection Strength

2.250
  1. Effects of GrandFusion Diet on Cognitive Impairment in Transgenic Mouse Model of Alzheimer's Disease. Nutrients. 2020 Dec 30; 13(1).
    View in: PubMed
    Score: 0.341
  2. High-Sodium Diet Has Opposing Effects on?Mean Arterial Blood Pressure and?Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2016 10 04; 54(3):1061-1072.
    View in: PubMed
    Score: 0.254
  3. Transcranial laser therapy attenuates amyloid-? peptide neuropathology in amyloid-? protein precursor transgenic mice. J Alzheimers Dis. 2011; 23(3):521-35.
    View in: PubMed
    Score: 0.170
  4. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A?PP transgenic mice. J Alzheimers Dis. 2011; 25(2):295-307.
    View in: PubMed
    Score: 0.170
  5. The cysteine protease inhibitor, E64d, reduces brain amyloid-? and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, ?-secretase activity. J Alzheimers Dis. 2011; 26(2):387-408.
    View in: PubMed
    Score: 0.170
  6. Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse. Brain Res. 2008 Oct 31; 1238:143-53.
    View in: PubMed
    Score: 0.145
  7. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biol Chem. 2007 Sep; 388(9):979-83.
    View in: PubMed
    Score: 0.135
  8. GM6 Attenuates Alzheimer's Disease Pathology in APP Mice. Mol Neurobiol. 2019 Sep; 56(9):6386-6396.
    View in: PubMed
    Score: 0.075
  9. Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res. 1998 Jul 20; 799(2):257-63.
    View in: PubMed
    Score: 0.072
  10. A therapeutic cancer vaccine against GL261 murine glioma. J Transl Med. 2016 Jan 05; 14:1.
    View in: PubMed
    Score: 0.060
  11. Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury. J Biol Chem. 2014 May 09; 289(19):13142-54.
    View in: PubMed
    Score: 0.053
  12. Brain pyroglutamate amyloid-? is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J Alzheimers Dis. 2014; 41(1):129-49.
    View in: PubMed
    Score: 0.052
  13. Tyrosine phosphorylation of microtubule-associated protein kinase after transient ischemia in the gerbil brain. J Neurochem. 1992 Nov; 59(5):1955-8.
    View in: PubMed
    Score: 0.048
  14. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing A?PP containing the wild-type ?-secretase site sequence. J Alzheimers Dis. 2012; 29(4):827-40.
    View in: PubMed
    Score: 0.046
  15. Modulation of ornithine decarboxylase mRNA following transient ischemia in the gerbil brain. J Cereb Blood Flow Metab. 1991 Nov; 11(6):979-85.
    View in: PubMed
    Score: 0.045
  16. Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis. J Biol Chem. 2011 Feb 11; 286(6):4644-58.
    View in: PubMed
    Score: 0.042
  17. Inducible ornithine decarboxylase expression in brain subject to vasogenic oedema after transient ischaemia: relationship to C-fos gene expression. Acta Neurochir Suppl (Wien). 1990; 51:189-91.
    View in: PubMed
    Score: 0.040
  18. Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun. 2009 Aug 21; 386(2):284-8.
    View in: PubMed
    Score: 0.038
  19. Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation. 2008 Oct 23; 5:47.
    View in: PubMed
    Score: 0.037
  20. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am J Pathol. 2008 May; 172(5):1342-54.
    View in: PubMed
    Score: 0.035
  21. Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease. Biol Chem. 2007 Feb; 388(2):247-52.
    View in: PubMed
    Score: 0.032
  22. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003 Jul; 9(7):907-13.
    View in: PubMed
    Score: 0.025
  23. Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci. 2002 Jul 15; 22(14):5900-9.
    View in: PubMed
    Score: 0.024
  24. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Res. 2002 Jan 04; 924(1):90-7.
    View in: PubMed
    Score: 0.023
  25. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology. 1999 Oct 22; 53(7):1391-6.
    View in: PubMed
    Score: 0.020
  26. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab. 1998 Dec; 18(12):1283-7.
    View in: PubMed
    Score: 0.018
  27. Induction of PGH synthase and c-fos mRNA during early reperfusion of ischemic rat brain. Brain Res Mol Brain Res. 1996 Jan; 35(1-2):339-43.
    View in: PubMed
    Score: 0.015
  28. Ischemic induction of protooncogene expression in gerbil brain. J Mol Neurosci. 1991; 2(4):217-28.
    View in: PubMed
    Score: 0.011
  29. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem. 2008 Jul; 106(1):475-85.
    View in: PubMed
    Score: 0.009
  30. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum Mol Genet. 2005 Feb 01; 14(3):447-60.
    View in: PubMed
    Score: 0.007
  31. Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. Neurosci Res. 2003 Apr; 45(4):437-45.
    View in: PubMed
    Score: 0.006
  32. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci. 2003 Mar 15; 23(6):1992-6.
    View in: PubMed
    Score: 0.006
  33. Abeta deposition is essential to AD neuropathology. J Alzheimers Dis. 2002 Jun; 4(3):133-8.
    View in: PubMed
    Score: 0.006
  34. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. J Alzheimers Dis. 2002 Jun; 4(3):145-54.
    View in: PubMed
    Score: 0.006
  35. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A. 2001 Feb 13; 98(4):1952-7.
    View in: PubMed
    Score: 0.005
  36. Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice. J Neurochem. 2000 Apr; 74(4):1579-86.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.